Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Dr Lal Pathlabs informs about schedule of analyst meet

04 Sep 2019

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting. 

The above information is a part of company’s filings submitted to BSE.

Related Dr. Lal Pathlabs Ltd. Links:

Dr. Lal Pathlabs Share Price

3554.55 -177.95 (-4.77%) Jul 30, 18:01
1 Year Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 4034.40
Aster DM Healthcare 163.30
Narayana Hrudayalay 490.00
Dr. Lal Pathlabs 3554.55
Metropolis Health. 2844.85
View more..
Sensex vs Dr. Lal Pathlabs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback